Y-mAbs Therapeutics settlements

Y-mAbs Therapeutics is the subject of a securities class action settlement with a total fund of $19,650,000.00, covering persons or entities who purchased Y-mAbs stock between October 6, 2020 and October 28, 2022. Claimants were required to submit documentation supporting their purchases. Note that the official claim deadline of October 7, 2024 has passed; this record is preserved for reference.

Check what you may be owed Free · takes 20 seconds

Published directory

1 published record

Proof required

False Advertising

Y Mabs

Y-mAbs Therapeutics, Inc. settled a securities class action for $19,650,000, resolving claims that investors were misled about the company between 2020 and 2022. The settlement covered purchasers of Y-mAbs stock during that period, and the fund has already been distributed. The claim filing window closed October 7, 2024.

Claim window closed Evidence-verified

Related companies with published settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record shows its official-evidence status — and you open the official claim form yourself.

Check what you may be owed Browse all settlements